Founded
Address
Alta Partners LP
One Embarcadero Center
37th Floor
San Francisco, CA 94111
United States
Phone
Email
Website
Recent investment activity
KANDO id: 30601
Corporate information
Registration country
Company type
Venture capital firm based in San Francisco which invests primarily in biotechnology and life science companies.Funding rounds
Investment activity status
Active investor
Selected investments
Displaying 126 - 150 of 152| Company | Profile | Country | Date | Funding | ||
|---|---|---|---|---|---|---|
![[current-page:title] logo](/sites/default/files/styles/icon/public/default_images/_no-logo.png?itok=AH4pbDYM){kind=icon}
|
Aerovance Inc | N/A | ||||
|
|
Aerovance Inc | Series C | ||||
|
|
Agami Systems Inc | Series C Initial investment | ||||
|
|
Agensys Inc | N/A | ||||
|
Alba Therapeutics Corp | N/A | ||||
|
|
aTyr Pharma Inc | Series C | ||||
|
|
aTyr Pharma Inc | Series B | ||||
|
|
Avid Radiopharmaceuticals Inc | Series D | ||||
|
|
Callisto Pharmaceuticals Inc | Public biotechnology company that develops novel therapeutics to treat cancer. | N/A | |||
|
|
Coapt Systems Inc | Coapt Systems develops, manufactures and markets a range of bio-absorbable implants for use in soft tissue fixation. | Debt | |||
|
|
Coapt Systems Inc | Coapt Systems develops, manufactures and markets a range of bio-absorbable implants for use in soft tissue fixation. | Series E | |||
|
|
Coapt Systems Inc | Coapt Systems develops, manufactures and markets a range of bio-absorbable implants for use in soft tissue fixation. | Series D | |||
|
|
Coapt Systems Inc | Coapt Systems develops, manufactures and markets a range of bio-absorbable implants for use in soft tissue fixation. | Series C | |||
|
|
deCODE genetics Inc | N/A | ||||
|
Lumena Pharmaceuticals Inc | Series A | ||||
|
|
MacroGenics Inc | Biotechnology company that develops immunotherapeutics to treat autoimmune disorders, cancer and infectious diseases. | N/A | |||
|
Nanomix Inc | N/A | ||||
|
|
Netli Inc | Global service provider for accelerating applications and content over the Internet. | N/A | |||
|
|
OPAL Therapeutics Pty Ltd | Series A | ||||
|
|
Portola Pharmaceuticals Inc | N/A | ||||
|
|
Terawave Communications Inc | Leading GPON Innovator. | Series B | |||
|
TransMedics Inc | Series E | ||||
|
|
TransMedics Inc | Series D | ||||
|
|
TransMedics Inc | Series B | ||||
|
|
TransMedics Inc | Series A led the round |